Orchestra BioMed Holdings, Inc./$OBIO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.
Ticker
$OBIO
Sector
Primary listing
Employees
86
Headquarters
Website
OBIO Metrics
BasicAdvanced
$239m
-
-$1.02
0.50
-
Price and volume
Market cap
$239m
Beta
0.5
52-week high
$5.42
52-week low
$2.20
Average daily volume
259k
Financial strength
Current ratio
7.027
Quick ratio
6.901
Long term debt to equity
29.556
Total debt to equity
31.096
Interest coverage (TTM)
-28.66%
Profitability
EBITDA (TTM)
-54.628
Gross margin (TTM)
99.46%
Net profit margin (TTM)
-166.96%
Operating margin (TTM)
-167.96%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
-43.02%
Return on equity (TTM)
-161.12%
Valuation
Price to revenue (TTM)
6.568
Price to book
5.68
Price to tangible book (TTM)
5.68
Price to free cash flow (TTM)
-3.903
Free cash flow yield (TTM)
-25.62%
Free cash flow per share (TTM)
-1.022
Growth
Revenue change (TTM)
1,033.89%
Earnings per share change (TTM)
-42.48%
3-year revenue growth (CAGR)
104.42%
3-year earnings per share growth (CAGR)
-19.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs